AI-Powered detectors aim to prevent errors in nuclear medicine
NCT ID NCT07174089
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new AI system that uses a special radiation detector to spot leaks when radioactive drugs are given to patients during PET scans or cancer therapy. The goal is to make these procedures safer and improve the quality of the images. Researchers will study 1,500 patients to see if the AI can reliably detect leaks and help doctors correct for them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- RadEye SPRD-ER radiation detector
- What this could lead to
- If successful, this could make nuclear medicine scans and therapies safer by catching leaks early and improving image accuracy.
- What could go wrong
- This is an early observational study focused on developing new methods, not testing a treatment. The AI models may not work reliably in all hospital settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS UNDERGOING PET/CT INVESTIGATION OR NUCLEAR MEDICINE THERAPY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda USL IRCCS di Reggio Emilia
RECRUITINGReggio Emilia, Italy
Contact